Details about Susan Golder

Access statistics for papers by Susan Golder.

Last updated 2022-09-29. Update your information in the RePEc Author Service.

Short-id: pgo960

Working Papers

2021

1. Who is Tweeting? A Scoping Review of Methods to Establish Race and Ethnicity from Twitter Datasets
   SocArXiv, Center for Open Science

Journal Articles

2022

1. Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media
   Drug Safety, 2022, 45, (9), 971-981 View citations (1)

2021

2. A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews
   Drug Safety, 2021, 44, (2), 167-179 View citations (1)
3. Alcohol, cardiovascular disease and industry funding: A co-authorship network analysis of systematic reviews
   Social Science & Medicine, 2021, 289, (C)
4. Correction to: A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews
   Drug Safety, 2021, 44, (2), 259-259 View citations (1)

2019

5. Pharmacoepidemiologic Evaluation of Birth Defects from Health-Related Postings in Social Media During Pregnancy
   Drug Safety, 2019, 42, (3), 389-400 View citations (1)

2018

6. Inadequate harms reporting in randomized control trials of antibiotics for pediatric acute otitis media: a systematic review
   Drug Safety, 2018, 41, (10), 933-938
7. Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab
   Drug Safety, 2018, 41, (12), 1397-1410 View citations (2)

2016

8. Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review
   PLOS Medicine, 2016, 13, (9), 1-22 View citations (6)

2013

9. Comparison of Pooled Risk Estimates for Adverse Effects from Different Observational Study Designs: Methodological Overview
   PLOS ONE, 2013, 8, (8), 1-9 View citations (2)

2011

10. Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview
    PLOS Medicine, 2011, 8, (5), 1-13 View citations (11)